Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-25 to 2025-09-16
Current total value of award: $10525.54
Description: 4569310002!TYSABRI 300 MG/15 ML VIAL 15ML